Invesco Health Care Fund Class Y (GGHYX)
| Fund Assets | 1.26B |
| Expense Ratio | 0.81% |
| Min. Investment | $1,000 |
| Turnover | 59.00% |
| Dividend (ttm) | 2.20 |
| Dividend Yield | 5.46% |
| Dividend Growth | 20.01% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 18, 2025 |
| Previous Close | 40.26 |
| YTD Return | -0.91% |
| 1-Year Return | 7.21% |
| 5-Year Return | 20.77% |
| 52-Week Low | 33.55 |
| 52-Week High | 42.71 |
| Beta (5Y) | n/a |
| Holdings | 76 |
| Inception Date | Oct 3, 2008 |
About GGHYX
The Invesco Health Care Fund Class Y is an actively managed mutual fund specializing in the health care sector. Its primary objective is to provide long-term capital growth by investing in equity securities of leading health care companies around the world. The fund holds a diversified portfolio, with a significant emphasis on U.S.-based health care firms but also includes notable positions in international companies. Core portfolio allocations span across key industry segments such as health care equipment, biotechnology, pharmaceuticals, life sciences tools and services, health care facilities, and managed health care. The fund typically invests in industry leaders with strong management teams and a demonstrated track record of innovation and operational excellence. With around 70-80 individual holdings and over $1 billion in assets under management, it serves as a targeted option for investors seeking exposure to the dynamics and growth potential within global health care markets. Fund management emphasizes rigorous stock selection, leveraging in-depth sector expertise to navigate industry risks including regulatory changes, pricing pressures, and technological disruptions.
Performance
GGHYX had a total return of 7.21% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.02%.
Top 10 Holdings
45.24% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.38% |
| Boston Scientific Corporation | BSX | 7.71% |
| Cencora, Inc. | COR | 4.77% |
| AbbVie Inc. | ABBV | 4.71% |
| AstraZeneca PLC | AZN | 4.00% |
| argenx SE | ARGX | 3.60% |
| Gilead Sciences, Inc. | GILD | 3.16% |
| McKesson Corporation | MCK | 3.13% |
| Welltower Inc. | WELL | 2.45% |
| Tenet Healthcare Corporation | THC | 2.33% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2025 | $2.2025 | Dec 18, 2025 |
| Dec 16, 2024 | $1.8353 | Dec 16, 2024 |
| Dec 16, 2021 | $9.9297 | Dec 16, 2021 |
| Dec 15, 2020 | $0.5793 | Dec 15, 2020 |
| Dec 13, 2019 | $1.5683 | Dec 13, 2019 |
| Dec 14, 2018 | $2.9024 | Dec 14, 2018 |